Novel bacterial ADP-ribosylating toxins: structure and function

被引:160
|
作者
Simon, Nathan C. [1 ]
Aktories, Klaus [2 ]
Barbieri, Joseph T. [1 ]
机构
[1] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[2] Univ Freiburg, Inst Expt & Clin Pharmacol & Toxicol, D-79104 Freiburg, Germany
基金
美国国家卫生研究院;
关键词
ISLET-ACTIVATING PROTEIN; COMPLETE GENOME SEQUENCE; ADENOSINE-DIPHOSPHATE-RIBOSYLATION; SMALL NUCLEAR RIBONUCLEOPROTEIN; ESCHERICHIA-COLI ENTEROTOXIN; SALMONELLA-ENTERICA SPVB; HEAT-LABILE ENTEROTOXIN; CELL LINEAGE ABLATION; BOTULINUM C2 TOXIN; RHO GENE-PRODUCT;
D O I
10.1038/nrmicro3310
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Bacterial ADP-ribosyttransferase toxins (bARTTs) transfer ADP-ribose to eukaryotic proteins to promote bacterial pathogenesis. In this Review, we use prototype bARTTs, such as diphtheria toxin and pertussis toxin, as references for the characterization of several new bARTTs from human, insect and plant pathogens, which were recently identified by bioinformatic analyses. Several of these toxins, including cholix toxin (ChxA) from Vibrio cholerae, SpyA from Streptococcus pyogenes, HopU1 from Pseudomonas syringoe and the Tcc toxins from Photorhabdus luminescens, ADP-ribosylate novel substrates and have unique organizations, which distinguish them from the reference toxins. The characterization of these toxins increases our appreciation of the range of structural and functional properties that are possessed by bARTTs and their roles in bacterial pathogenesis.
引用
收藏
页码:599 / 611
页数:13
相关论文
共 50 条
  • [21] Functional comparison of the NAD binding cleft of ADP-ribosylating toxins
    Dolan, KM
    Lindenmayer, G
    Olson, JC
    BIOCHEMISTRY, 2000, 39 (28) : 8266 - 8275
  • [22] How do ADP-ribosylating toxins discriminate for their target substrates?.
    Patel, R
    Peltier, H
    Read, J
    Blanke, SR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U178 - U178
  • [23] The ARTT motif and a unified structural understanding of substrate recognition in ADP-ribosylating bacterial toxins and eukaryotic ADP-ribosyltransferases
    Han, S
    Tainer, JA
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2002, 291 (6-7) : 523 - 529
  • [24] How do ADP-ribosylating toxins discriminate for their target substrates?
    Patel, R
    Peltier, H
    Read, J
    Blanke, SR
    BIOCHEMISTRY, 2002, 41 (28) : 8993 - 8993
  • [26] Cyclophilin 40 is a novel interaction partner of bacterial ADP-ribosylating toxins providing a starting point for new therapeutic strategies
    Ernst, K.
    Schiene-Fischer, C.
    Barth, H.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2015, 388 : S81 - S81
  • [27] ADP-ribosylating and glucosylating toxins as tools to study secretion in RBL cells
    Prepens, U
    Just, I
    Hofmann, F
    Aktories, K
    ADP-RIBOSYLATION IN ANIMAL TISSUES: STRUCTURE, FUNCTION, AND BIOLOGY OF MONO (ADP-RIBOSYL) TRANSFERASES AND RELATED ENZYMES, 1997, 419 : 349 - 353
  • [28] ADP-ribosylating bacterial enzymes for the targeted control of mucosal tolerance and immunity
    Lycke, N
    ORAL TOLERANCE: NEW INSIGHTS AND PROSPECTS FOR CLINICAL APPLICATION, 2004, 1029 : 193 - 208
  • [29] Transcutaneous immunization with bacterial ADP-ribosylating exotoxins as antigens and adjuvants
    Glenn, GM
    Scharton-Kersten, T
    Vassell, R
    Matyas, GR
    Alving, CR
    INFECTION AND IMMUNITY, 1999, 67 (03) : 1100 - 1106
  • [30] Targeted delivery of an ADP-ribosylating bacterial toxin into cancer cells
    Zahaf, N. -I.
    Lang, A. E.
    Kaiser, L.
    Fichter, C. D.
    Lassmann, S.
    McCluskey, A.
    Augspach, A.
    Aktories, K.
    Schmidt, G.
    SCIENTIFIC REPORTS, 2017, 7